Buy ORTHOVISC® online at Kinami Health and order genuine sodium hyaluronate injections for professional orthopedic use. ORTHOVISC® is a high molecular weight, non-animal hyaluronic acid viscosupplement designed for intra-articular injection in patients with knee osteoarthritis. It supports joint lubrication, cushioning, and mobility when the natural synovial fluid becomes reduced or less effective. Kinami Health supplies authentic ORTHOVISC® products with wholesale options and reliable delivery to clinics and medical professionals.
Kinami Health provides clinics, orthopedic specialists, and medical distributors with trusted access to genuine ORTHOVISC® products. When you buy ORTHOVISC® online through Kinami Health, you can source authentic orthopedic injections with professional support, competitive wholesale pricing, and fast delivery for clinical use.
ORTHOVISC® is selected by practitioners looking for a non-animal hyaluronic acid viscosupplement with a high molecular weight formulation. It is used as a knee osteoarthritis injection to help restore joint lubrication and support smoother movement in affected joints.
Benefits of ordering ORTHOVISC® from Kinami Health include:
Whether you need to order ORTHOVISC® for a clinic, orthopedic practice, or medical distribution channel, Kinami Health offers a reliable way to buy authentic HA viscosupplements online.
The ORTHOVISC® product range available at Kinami Health currently includes:
ORTHOVISC® 2ml is a sodium hyaluronate viscosupplement used for intra-articular injection in the knee joint. It is designed to supplement the natural synovial fluid in patients with knee osteoarthritis, helping improve lubrication and cushioning inside the joint.
Only ORTHOVISC® products currently available in the product grid should be listed on this page. If ORTHOVISC® Mini or ORTHOVISC® One are not stocked or linked as live SKUs, they should be removed from the product range section to avoid confusing buyers and weakening trust.
ORTHOVISC®, Synvisc, and Monovisc are all viscosupplement injections used in the management of knee osteoarthritis, but they differ in formulation, injection schedule, and hyaluronic acid source.
ORTHOVISC® is a high molecular weight, non-animal sodium hyaluronate viscosupplement produced through bacterial fermentation. It is commonly used as a multi-injection treatment course and is designed to restore joint lubrication in the knee.
Synvisc is another orthopedic injection option used for knee osteoarthritis. It contains hylan G-F 20 and is often compared with ORTHOVISC® by practitioners choosing between different HA-based viscosupplements.
Monovisc is a single-injection hyaluronic acid viscosupplement option. It may be preferred when a one-injection protocol is suitable, while ORTHOVISC® may be selected when a multi-injection treatment plan is preferred.
When comparing ORTHOVISC® vs Synvisc vs Monovisc, clinics usually consider:
For related options, visit the Synvisc and Monovisc brand pages or browse the orthopedic injections category.
ORTHOVISC® works by supplementing the natural synovial fluid in the knee joint. In patients with osteoarthritis, synovial fluid can lose viscosity and elasticity, reducing its ability to lubricate and cushion the joint. ORTHOVISC® contains sodium hyaluronate, a form of hyaluronic acid that helps restore joint lubrication and support smoother movement.
As a high molecular weight HA viscosupplement, ORTHOVISC® is designed to improve the mechanical environment inside the knee joint. It may help reduce pain linked to knee osteoarthritis and support improved mobility as part of a professional treatment plan.
ORTHOVISC® is typically administered as a series of intra-articular injections. The exact number of injections and treatment schedule should be determined by a qualified healthcare professional based on the patient’s condition, clinical history, and treatment goals.
ORTHOVISC® should only be administered by trained and qualified medical professionals experienced in intra-articular injection techniques.
Before injection, the treatment area should be prepared using appropriate aseptic technique. If joint effusion is present, aspiration may be performed before administering ORTHOVISC®. The product is injected directly into the affected knee joint using a suitable sterile needle, commonly within the 18–21G range depending on practitioner preference and clinical protocol.
General administration considerations include:
ORTHOVISC® is intended for professional use only and should not be self-administered.
ORTHOVISC® is generally well tolerated when administered correctly by a qualified healthcare professional. As with other intra-articular HA injections, side effects may occur at or around the injection site.
Possible side effects may include:
Patients should be assessed by a healthcare professional before treatment to confirm suitability. ORTHOVISC® should not be used in patients with known hypersensitivity to any component of the product or in cases where infection or skin disease is present at the injection site.
All treatment decisions, injection frequency, and aftercare recommendations should be made by a licensed medical professional.
